Atlas Trials

Trial of Alpha One Antitrypsin Inhalation in Treating Patient With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

Clinical trial NCT04385836 · UNKNOWN

Trial details

NCT number
NCT04385836
Sponsor
Ministry of Health, Saudi Arabia
Status
UNKNOWN
Phase
Early Phase 1
Study type
INTERVENTIONAL
Coronavirus
Start date
2020-06-01
Primary completion
2020-09-01
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.